Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Synovus Financial Corp (SNV.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-2551.72-No Rating
2023-03-1529.3133.00Neutral
2023-04-1029.4831.00Neutral
2023-04-2430.7633.00Neutral
2023-07-1031.2131.00Neutral
2023-07-2433.0334.00Neutral
2023-09-2827.3730.00Neutral
2023-10-2525.1227.50Neutral
2024-01-0837.2542.00Buy
2024-01-2238.4344.00Buy
2024-07-0839.3245.00Buy
2024-07-1945.0951.00Buy
2024-12-1654.7568.00Buy
2025-04-0942.8260.00Buy
2025-05-0744.9262.00Buy

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 25% above the MRA for a Buy rating, and at -25% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.